LifeStance Health (LFST) Operating Leases (2022 - 2026)

LifeStance Health (LFST) has 5 years of Operating Leases data on file, last reported at $148.8 million in Q1 2026.

• Quarterly Operating Leases changed 0.38% year-over-year to $148.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $148.8 million (changed 0.38% YoY) and the FY2025 annual result came in at $148.6 million, changed 0.1% from the prior year.
• Operating Leases was little changed at $148.8 million in Q1 2026 per LFST's latest filing, from $148.6 million in the prior quarter.
• Across five years, Operating Leases topped out at $212.6 million in Q4 2022 and bottomed at $143.4 million in Q2 2025.
• The 5-year median for Operating Leases is $162.2 million (2024), against an average of $170.0 million.
• The widest annual swing landed in 2024, when Operating Leases fell 19.38%; it then decreased 0.1% in 2025.
• Tracing LFST's Operating Leases over 5 years: stood at $212.6 million in 2022, then decreased by 14.69% to $181.4 million in 2023, then declined by 18.01% to $148.7 million in 2024, then fell by 0.1% to $148.6 million in 2025, then rose by 0.18% to $148.8 million in 2026.
• Per Business Quant, the three latest LFST Operating Leases figures stand at $148.8 million (Q1 2026), $148.6 million (Q4 2025), and $144.2 million (Q3 2025).

Peer Comparison